Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
The FDA revised the Emergency Use Authorization (EUA) for Evusheld (tixagevimab co-packaged with cilgavimab) to limit its use to when the combined frequency of non-susceptible SARS-CoV-2 variants ...
read more
Wednesday, February 01, 2023
Translocation from cytoplasm to nucleus and integration of reverse-transcribed SARS-CoV-2 spike mRNA into the genomic DNA of COVID-19 mRNA-vaccinated individuals positive for HIV-1 or other retroviral...
read more
Wednesday, February 08, 2023
BD (Becton, Dickinson and Company) has received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A...
read more
Tuesday, February 14, 2023
Novavax, Inc. announced a modification to its existing agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, to deliver up to 1.5 ...
read more
A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, ...
read more
Throughout the COVID-19 pandemic, to protect the health and safety of Canadians, the Government of Canada has taken a prudent and measured approach to adjusting border measures.
read more
CSL officially opened a new state-of-the-art research and development (R&D) center in Waltham, Massachusetts.
read more
As the world races towards a post-pandemic future, the surge in demand for single-use systems (SUS) and devices is revolutionizing the production of biologics and vaccines. In BioPlan’s 19th Annual ...
read more
Sometimes (well, maybe more than that) I get a little frustrated with society. It’s almost like we have given up on thinking for ourselves; having a little common sense.
One example of this is the ...
read more
Wednesday, April 19, 2023
The FDA amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
read more
The FDA has approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk ...
read more
InflaRx announced the commercial launch of Gohibic (vilobelimab) in the US In April 2023, Gohibic was granted an Emergency Use Authorization (EUA) by the FDA for the treatment of COVID-19 in ...
read more
Thursday, August 03, 2023
PrecisionLife has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic ...
read more
Novavax announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate ...
read more
Wednesday, August 30, 2023
Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended marketing authorization for the companies’ Omicron XBB.1...
read more